Skip to main content
SpringerLink
Log in

Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD)

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Badley AD, Portela DF, Patel R, Kyle RA, Habermann TM, Strickler JG, Ilstrup DM, Wiesner RH, Groen P de, Walker RC, Paya CV (1996) Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced post-transplant lymphoproliferative disorder. Liver Transplant Surg 2: 375

    Google Scholar 

  2. Benkerrou M, Durandy A, Fischer A (1993) Therapy for transplant-related lymphoproliferative diseases. Hematol Oncol Clin North Am 7:467

    PubMed  Google Scholar 

  3. Bhatia S, Ramsay NKC, Steinbuch M, Dusenbery KE, Shapiro RS, Weisdorf DJ, Robison DJ, Miller JS, Neglia JP (1996) Malignant neoplasms following bone marrow transplantation. Blood 87: 3633

    PubMed  Google Scholar 

  4. Brumbaugh J, Baldwin JC, Stinson EB, et al (1985) Quantitative analysis of immunosuppression in cyclosporine-treated heart transplant patients with lymphoma. Heart Transplant 4: 307

    Google Scholar 

  5. Burke GW, Cirocco R, Hensley G, Reddy R, Jeffers L, Schiff E, Miller J (1992) The rapid development of a fatal, disseminated B cell lymphoma following liver transplantation-serial changes in levels of soluble serum interleukin 2 and interleukin 4 (B cell growth factor). Transplantation 53: 1148

    PubMed  Google Scholar 

  6. Burtin P, Guerci A, Boman F, Dopff C, Pinelli G, Haberer JP, Villemot JP (1993) Malignant lymphoma in the donor heart after heart transplantation. Eur Heart J 14: 1143

    PubMed  Google Scholar 

  7. Cantarovich M, Barkun JS, Forbes RD, Kosiuk JP, Tchervenkov JI (1998) Successful treatment of post-transplant lymphoproliferative disorder with interferon-alpha and intravenous immunoglobulin. Clin Transplant 12:109

    PubMed  Google Scholar 

  8. Chadburn A, Cesarman E, Knowles DM (1997) Molecular pathology of posttransplantation lymphoproliferative disorders. Semin Diagn Pathol 14:15

    Google Scholar 

  9. Chadburn A, Chen JM, Hsu DT, Frizzera G, Cesarman E, Garrett TJ, Mears JG, Zangwill SD, Addonizio LJ, Michler RE, Knowles DM (1998) The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant. Cancer 82: 1978

    Google Scholar 

  10. Chen JM, Barr ML, Chadbum A, et al (1993) Management of lymphoproliferative disorders after cardiac transplantation. Ann Thorac Surg 56: 527

    PubMed  Google Scholar 

  11. Chetty R, Biddolph S, Kaklamanis L, Cary N, Stewart S, Giatromanolaki A, Gatter K (1996) bcl-2 protein is strongly expressed in post-transplant lymphoproliferative disorders. J Pathol 180: 254

    PubMed  Google Scholar 

  12. Cherry R, Biddolph S, Garter K (1997) An immunohistochemical analysis of Reed-Stemberg-like cells in posttransplantation lymphoproliferative disorders: the possible pathogenetic relationship to Reed-Sternberg cells in Hodgkin's disease and Reed-Stemberg-like cells in non-Hodgkin's lymphomas and reactive conditions. Hum Pathol 28:493

    PubMed  Google Scholar 

  13. Cheung AN, Chan AC, Chung LP, Chan TM, Cheng IK, Chan KW (1998) Post-transplantation lymphoproliferative disorder of donor origin in a sex-mismatched renal allograft as proven by chromosome in situ hybridization. Mod Pathol 11: 99

    PubMed  Google Scholar 

  14. Cohen JI (1991) Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine 70:137

    PubMed  Google Scholar 

  15. Crawford DH, Thomas JA, Janossy G, Sweny P, Fernando ON, Moorhead JF, Thompson JH (1980) Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft. [Letter] Lancet 1: 1355

    PubMed  Google Scholar 

  16. Darenkov IA, Marcarelli MA, Basadonna GP, Friedman AL, Lorber KM, Howe JG, Crouch J, Bia MJ, Kliger AS, Lorber MI (1997) Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy. Transplantation 64: 848

    PubMed  Google Scholar 

  17. Delecluse HJ, Kremmer E, Rouault JP, Cour C, Bomkamm G, Berger F (1995) The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders. Am J Pathol 146: 1113

    PubMed  Google Scholar 

  18. Delecluse HJ, Rouault JP, Jeammot B, Kremmer E, Bastard C, Berger F (1995) Bcl6/Laz3 rearrangements in post-transplant lymphoproliferative disorders. Br J Haematol 91: 101

    PubMed  Google Scholar 

  19. Demircin G, Rees L (1997) Retransplantation after post-transplant lymphoproliferative disease. Pediatr Nephrol 11: 358

    PubMed  Google Scholar 

  20. Dockrell DH, Strickler JG, Paya CV (1998) Epstein-Barr virus-induced T cell lymphoma in solid organ transplant recipients. Clin Infect Dis 26: 180

    PubMed  Google Scholar 

  21. Dusenbery D, Nalesnik MA, Locker J, Swerdlow SH (1997) Cytologic features of post-transplant lymphoproliferative disorder. Diagn Cytopathol 16:489

    PubMed  Google Scholar 

  22. Emanuel DJ, Lucas KG, Mallory GB Jr, Edwards-Brown MK, Pollok KE, Conrad PD, Robertson KA, Smith FO (1997) Treatment of posttransplant lymphoproliferative disease in the central nervous system of a lung transplant recipient using allogeneic leukocytes. Transplantation 63: 1691

    PubMed  Google Scholar 

  23. Faro A, Kurland G, Michaels MG, Dickman PS, Greally PG, Spichty KJ, Noyes BB, Boas SR, Fricker FJ, Armitage JM, Zeevi A (1996) Interferon-alpha affects the immune response in post-transplant lymphoproliferative disorder. Am J Respir Crit Care Med 153:1442

    PubMed  Google Scholar 

  24. Finn L, Reyes J, Bueno J, Yunis E (1998) Epstein-Barr virus infections in children after transplantation of the small intestine. Am J Surg Pathol 22: 299

    PubMed  Google Scholar 

  25. Frizzera G (1992) Atypical lymphoproliferative disorders. In: Knowles DM (ed) Neoplastic hematopathology. Williams and Wilkins, Baltimore, p 459

    Google Scholar 

  26. Frizzera G, Hanto DW, Gajl-Peczalska KJ, Rosai J, McKenna RW, Sibley RK, Holahan KP, Lindquist LL (1981) Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 41:4262

    PubMed  Google Scholar 

  27. Gattuso P, Castelli ML, Peng Y, Reddy VB (1997) Posttransplant lymphoproliferative disorders: a fineneedle aspiration biopsy study. Diagn Cytopathol 16: 392

    PubMed  Google Scholar 

  28. Geis WP, Iwatsuki S, Molnar Z, Giacchino JL, Kerman RH, Ing TS, Hano JE (1978) Pseudolymphoma in renal allograft recipients. Arch Surg 113: 461

    PubMed  Google Scholar 

  29. Gollin SM, Cen H, Storto PD, Wyman PL, Malone P, Anderson SJ, Herberman RB, Nalesnik MA, Locker J, Ho M, McKnight J (1990) Consistent nonclonal cytogenetic abnormalities in post-transplant lymphoproliferative disease [Abstract]. Am J Hum Genet 47 [Suppl 3]: A7

    Google Scholar 

  30. Gonthier DM, Hartman G, Holley JL (1992) Posttransplant lymphoproliferative disorder presenting as an isolated skin lesion. Am J Kidney Dis 19: 600

    PubMed  Google Scholar 

  31. Gross TG, Hinrichs SH, Davis JR, Mitchell D, Bishop MR, Wagner JE (1998) Depletion of EBV-infected cells in donor marrow by counterflow elutriation. Exp Hematol 26: 395

    PubMed  Google Scholar 

  32. Hanasono MM, Kamel OW, Chang PP, Rizeq MN, Billingham ME, Rijn M van de (1995) Detection of Epstein-Barr virus in cardiac biopsies of heart transplant patients with lymphoproliferative disorders. Transplantation 60: 471

    PubMed  Google Scholar 

  33. Hanson MN, Morrison VA, Peterson BA, Stieglbauer KT, Kubic VL, McCormick SR, McGlennen RC, Manivel JC, Brunning RD, Litz CE (1996) Posttransplant T -cell lymphoproliferative disorders — an aggressive, late complication of solid-organ transplantation [see comments]. Blood 88: 3626

    PubMed  Google Scholar 

  34. Hanto DW, Frizzera G, Gajl-Peczalska KJ, et al (1985) Acyclovir therapy of Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. Transplant Proc 17: 89

    Google Scholar 

  35. Harris NL, Ferry JA, Swerdlow SH (1997) Posttransplant lymphoproliferative disorders (PTLD): summary of Society for Hematopathology Workshop. Semin Diagn Pathol 14: 8

    PubMed  Google Scholar 

  36. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361

    PubMed  Google Scholar 

  37. Heslop HE, Rooney CM (1997) Adoptive cellular immunotherapy for EBV lymphoproliferative disease. Immunol Rev 157:217

    PubMed  Google Scholar 

  38. Hickey DP, Nalesnik MA, Vivas CA, Lopatin WB, Jordan ML, Starzl TE, Hakala TR (1990) Renal retransplantation in patients who lost their allografts during management of previous post-transplant lymphoproliferate diseases. Clin Transplant 4: 187

    Google Scholar 

  39. Ho M, Jaffe R, Miller G, Breinig MK, Dummer IS, Makowka L, Atchison RW, Karrer F, Nalesnik MA, Starzl TE (1988) The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 45: 719

    PubMed  Google Scholar 

  40. Hsi ED, Picken MM, Alkan S (1998) Post-transplantation lymphoproliferative disorder of the NK-cell type: a case report and review of the literature. Mod Pathol 11: 479

    PubMed  Google Scholar 

  41. Hubscher SG, Williams A, Davison SM, Young LS, Niedobitek G (1994) Epstein-Barr virus in inflammatory diseases of the liver and liver allografts: an in situ hybridization study. Hepatology 20: 899

    PubMed  Google Scholar 

  42. Keay S, Oldach D, Wiland A, Klassen D, Schweitzer E, Abruzzo LV, Kumar D, Bartlett S (1998) Posttransplantation lymphoproliferative disorder associated with OKT3 and decreased antiviral prophylaxis in pancreas transplant recipients. Clin Infect Dis 26: 596

    Google Scholar 

  43. Kershaw GR, Berger C, McQuain C, Al-Homsi AS, Pihan G, Quesenberry PJ, Woda BA, Knecht H (1997) Selective outgrowth of a posttransplant B-immunoblastic lymphomas expressing a latent membrane protein-1 deletion variant. Transplantation 64: 1079

    PubMed  Google Scholar 

  44. Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M (1996) Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 88: 242

    PubMed  Google Scholar 

  45. Klein G (1975) The Epstein-Barr virus and neoplasia. N Engl J Med 293: 1353

    PubMed  Google Scholar 

  46. Klein G (1994) Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 77: 791

    PubMed  Google Scholar 

  47. Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, Michler RE (1995) Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85: 552

    PubMed  Google Scholar 

  48. Koeppen H, Newell K, Baunoch DA, Vardiman JW (1998) Morphologic bone marrow changes in patients with posttransplantation lymphoproliferative disorders. Am J Surg Pathol 22: 208

    PubMed  Google Scholar 

  49. Kraus MD, Crawford DF, Kaleem Z, Shenoy S, MacArthur CA, Longtine JA (1998) T γ/δ hepatosplenic lymphoma in a heart transplant patient after an Epstein-Barr virus positive lymphoproliferative disorder: a case report. Cancer 82: 983

    PubMed  Google Scholar 

  50. Leblond V, Davi F, Charlotte F, Dorent R, Bitker MO, Sutton L, Gandjbakhch I, Binet JL, Raphael M (1998) Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? J Clin Oncol 16: 2052

    PubMed  Google Scholar 

  51. Locker J, Nalesnik M (1989) Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol 135: 977

    PubMed  Google Scholar 

  52. Lones MA, Lopez-Terrada D, Weiss LM, Shintaku IP, Said JW (1997) Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization. Arch Pathol Lab Med 121:701

    PubMed  Google Scholar 

  53. Lones MA, Shintaku IP, Weiss LM, Thung SN, Nichols WS, Geller SA (1997) Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus. Hum Pathol 28:533

    PubMed  Google Scholar 

  54. Malatack JJ, Gartner JC, Urbach AH, Zitelli BJ (1991) Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: a growing concern. J Pediatr 118: 667

    PubMed  Google Scholar 

  55. Manez R, Breinig MC, Linden P, Wilson J, Torre-Cisneros J, Kusne S, Dummer S, Ho M (1997) Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis 176: 1462

    PubMed  Google Scholar 

  56. Markin RS (1994) Manifestations of Epstein-Bart virus-associated disorders in liver. Liver 14: 1

    PubMed  Google Scholar 

  57. Martinez AJ, Ahdab-Barmada M (1993) The neuropathology of liver transplantation: Comparison of main complications in children and adults. Mod Pathol 6:25

    PubMed  Google Scholar 

  58. Maras AJ, Hertel BF, Rosai J, et al (1976) Post-transplant malignant lymphoma: distinctive morphologic features related to its pathogenesis. Am J Med 61: 716

    PubMed  Google Scholar 

  59. Mcgregor JM, Yu CCW, Lu QL, Cotter FE, Levison DA, Macdonald DM (1993) Posttransplant Cutaneous Lymphoma. J Am Acad Dermatol 29: 549

    PubMed  Google Scholar 

  60. Mentzer SJ, Longtine J, Fingeroth J, Reilly JJ, DeCamp MM, O'Donnell W, Swanson SJ, Faller DV, Sugarbaker DJ (1996) Immunoblastic lymphoma of donor origin in the allograft after lung transplantation. Transplantation 61:1720

    PubMed  Google Scholar 

  61. Mentzer SJ, Fingeroth J, Reilly JJ, Perrine SP, Faller DV (1998) Arginine butyrate-induced susceptibility to Ganciclovir in an Epstein-Barr-Virus-associated lymphoma. Blood Cells Mol Dis 24:114

    PubMed  Google Scholar 

  62. Miller WT Jr, Siegel SG, Montone KT (1997) Posttransplantation lymphoproliferative disorder: changing manifestations of disease in a renal transplant population. Crit Rev Diagn Imaging 38:569

    PubMed  Google Scholar 

  63. Nagington J, Gray J (1980) Cyclosporin A immunosuppression, Epstein-Barr antibody and lymphoma. Lancet II: 536

    Google Scholar 

  64. Nalesnik MA (1996) Posttransplantation lymphoproliferative disorders (PTLD): current perspectives. Semin Thorac Cardiovasc Surg 8:139

    PubMed  Google Scholar 

  65. Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, Makowka L, Ho M, Locker J (1988) The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 133: 173

    PubMed  Google Scholar 

  66. Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, Makowka L, Ho M, Locker J (1988) The pathology of post-transplant lymphoproliferative disorders occurring in the setting of Cyclosporine A-prednisone immunosuppression. Am J Pathol 133:173

    PubMed  Google Scholar 

  67. Nalesnik MA, Demetris AJ, Fung JJ, Starzl TE (1991) Lymphoproliferative disorders arising under immunosuppression with FK 506: Initial observations in a large transplant population. Transplant Proc 23:1108

    PubMed  Google Scholar 

  68. Nalesnik MA, Randhawa P, Demetris AJ, Casavilla A, Fung JJ, Locker J (1993) Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient. Cancer 72:2568

    PubMed  Google Scholar 

  69. Nast CC, Moudgil A, Zuo XJ, Toyoda M, Jordan SC (1997) Long-term allograft acceptance in a patient with posttransplant lymphoproliferative disorder: correlation with intragraft viral interleukin-10. Transplantation 64: 1578

    PubMed  Google Scholar 

  70. Newell KA, Alonso EM, Kelly SM, Rubin CM, Thistlethwaite JR Jr, Whitington PF (1997) Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children. J Pediatr 131: 98

    PubMed  Google Scholar 

  71. Niedobitek G, Mutimer DJ, Williams A, Whitehead L, Wilson P, Rooney N, Young LS, Hubscher SG (1997) Epstein-Barr- virus infection and malignant lymphomas in liver transplant recipients. Int J Cancer 73: 514

    PubMed  Google Scholar 

  72. O'Brien S, Bernert RA, Logan JL, Lien YH (1997) Remission of posttransplant lymphoproliferative disorder after interferon alfa therapy. J Am Sue Nephrol 8: 1483

    Google Scholar 

  73. Orazi A, Hromas RA, Neiman RS, Greiner TC, Lee CH, Rubin L, Haskins S, Heerema NA, Gharpure V, Abonour R, Stour EF, Cornetta K (1997) Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features. Am J Clin Pathol 107: 419

    PubMed  Google Scholar 

  74. Pageaux GP, Bonnardet A, Picot MC, Perrigault PF, Coste V, Navarro F, Fabre JM, Domergue J, Descomps B, Blanc P, Michel H, Larrey D (1998) Prevalence of monoclonal immunoglobulins after liver transplantation: relationship with posttransplant lymphoproliferative disorders. Transplantation 65: 397

    PubMed  Google Scholar 

  75. Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio AP, Small TN, Young JW, Kernan NA, O'Reilly RJ (1994) Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 330: 1185

    PubMed  Google Scholar 

  76. Penn I (1992) Immunosuppression — A contributing factor in lymphoma formation. Clin Transplant 6: 214

    Google Scholar 

  77. Penn I (1994) The problem of cancer in organ transplant recipients: an overview. Transplant Sci 4: 23

    PubMed  Google Scholar 

  78. Penn I, Porat G (1995) Central nervous system lymphomas in organ allograft recipients. Transplantation 59: 240

    PubMed  Google Scholar 

  79. Purighalla R, Shapiro R, Jordan ML, Scantlebury VP, Gritsch HA, Vivas C, Randhawa PS (1997) Acute renal allograft rejection in patients with Epstein-Barn virus associated post-transplant lymphoproliferative disorder. Clin Transplant 11: 574

    PubMed  Google Scholar 

  80. Randhawa PS, Jaffe R, Demetris AJ, Nalesnik M, Starzl TE, Chen YY, Weiss LM (1992) Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med 327: 1710

    PubMed  Google Scholar 

  81. Randhawa P, Demetris AJ, Pietrzak B, Nalesnik M (1996) Histopathology of renal posttransplant lymphoproliferation: comparison with rejection using the Banff schema. Am J Kidney Dis 28: 578

    PubMed  Google Scholar 

  82. Rea D, Delecluse HJ, Hamilton-Dutoit SJ, Marelle L, Joab I, Edelman L, Finet JF, Raphael M (1994) Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomas. French Study Group of Pathology for HIV-associated Tumors. Ann Oncol 5 [Suppl 1]: 113

    Google Scholar 

  83. Reyes J, Green M, Bueno J, Jabbour N, Nalesnik M, yunis E, Kocoshis S, Kauffman M, Todo S, Starzl TE (1996) Epstein Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation. Transplant Proc 28: 2768

    PubMed  Google Scholar 

  84. Rickinson AB (1995) Immune intervention against virus-associated human cancers. Ann Oncol 6 [Suppl 1]:69

    Google Scholar 

  85. Rickinson AB, Lee SP, Steven NM (1996) Cytotoxic T lymphocyte responses to Epstein-Barr virus. Curr Opin Immunol 8:492

    PubMed  Google Scholar 

  86. Rizkalla KS, Asfar SK, McLean CA, Garcia BM, Wall WJ, Grant DR (1997) Key features distinguishing post-transplantation lymphoproliferative disorders and acute liver rejection. Mod Pathol 10: 708

    PubMed  Google Scholar 

  87. Rooney CM, Loftin SK, Holladay MS, Brenner MK, Krance RA, Heslop HE (1995) Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease. Br J Haematol 89:98

    PubMed  Google Scholar 

  88. Rooney CM, Smith CA, Ng CYC, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE (1995) Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345: 9

    PubMed  Google Scholar 

  89. Rosendale B, Yousem SA (1995) Discrimination of Epstein-Barr virus-related posttransplant lymphoproliferations from acute rejection in lung allograft recipients. Arch Pathol Lab Med 119: 418

    PubMed  Google Scholar 

  90. Rowe DT, Qu L, Reyes J, Jabbour N, Yunis E, Putnam P, Todo S, Green M (1997) Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphproliferative disorders. J Clin Microbiol 35: 1612

    PubMed  Google Scholar 

  91. Sasaki TM, Pirsch JD, AM DA, Knechtle SJ, Kalayoglu M, Hafez GR, Sollinger HW (1997) Increased beta 2-microglobulin (B2 M) is useful in the detection of post-transplant lymphoproliferative disease (PTLD). Clin Transplant 11: 29

    PubMed  Google Scholar 

  92. Scheinfeld AG, Nador RG, Cesarman E, Chadbum A, Knowles DM (1997) Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders. Am J Pathol 151: 805

    PubMed  Google Scholar 

  93. Senderowicz AM, Vitetta E, Headlee D, Ghetie V, Uhr JW, Figg WD, Lush RM, Stetler-Stevenson M, Kershaw G, Kingma DW, Jaffe ES, Sausville EA (1997) Complete sustained response of a refractory, post-transplantation, large B-cell lymphoma to an anti-CD22 immunotoxin. Ann Intem Med 126: 882

    Google Scholar 

  94. Shapiro RS, Chauvenet A, McGuire W, Pearson A, Craft AW, McGlave P, Filipovich A (1988) Letter. Treatment of B-cell lymphoproliferative disorders with interferon-alpha and intravenous gamma globulin. N Engl J Med 318:1334

    PubMed  Google Scholar 

  95. Shapiro RS, McClain K, Frizzera G, Gajl-Peczalska KJ, Kersey JH, Blazar BR, Arthyur DC, Patton DF, Greenberg IS, Burke B, Ramsay NKC, McGlave P, Filipovich A (1988) Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood 71:1234

    PubMed  Google Scholar 

  96. Siddiqui MT, Reddy VB, Castelli MJ, Gattuso P (1997) Role of fine-needle aspiration in clinical management of transplant patients. Diagn Cytopathol 17:429

    PubMed  Google Scholar 

  97. Sokal EM, Antunes H, Beguin C, Bodeus M, Wallemacq P, Ville de Goyet J de, Reding R, Janssen M, Buts JP, Otte JB (1997) Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant patients treated with tacrolimus. Transplantation 64: 1438

    PubMed  Google Scholar 

  98. Starzl TE (1968) Discussion of Murray JE, Wilson RE, Tilney NL, et al: Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg 168:416

    PubMed  Google Scholar 

  99. Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, Rosenthal JT, Hakala TR, Shaw BW Jr, Hardesty RL, Atchison RW, Jaffe R, Bahnson HT (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under Cyclosporine-steroid therapy. Lancet I: 583

    Google Scholar 

  100. Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, Ramos H, Todo S, Tzakis A, Fung JJ, Nalesnik M, Rudert WA, Kocova M (1993) Cell migration and chimerism after whole organ transplantation: the basis of graft acceptance. Hepatology 17: 1127

    PubMed  Google Scholar 

  101. Stieber AO, Boillot O, Scotti-Foglieni C, Nalesnik MA, Gordon RD, Marino I, Mazzaferro V (1991) The surgical implications of the posttransplant lymphoproliferative disorders. Transplant Proc 23: 1477

    PubMed  Google Scholar 

  102. Swerdlow SH (1997) Classification of the posttransplant lymphoproliferative disorders: from the past to the present. Semin Diagn Pathol 14: 2

    PubMed  Google Scholar 

  103. Swinnen LJ (1997) Durable remission after aggressive chemotherapy for post-cardiac transplant lymphoproliferation. Leuk Lymphoma 28: 89

    PubMed  Google Scholar 

  104. Swinnen LJ, Costanzo-Nordin MK, Fisher SG, O'Sullivan EJ, Johnson MR, Heroux AL, Dizikes GJ, Pifarre R, Fisher RI (1990) Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 323:1723

    PubMed  Google Scholar 

  105. Swinnen LJ, Mullen GM, Carr TL, Costanzo MR, Fisher RI (1995) Aggressive treatment for postcardiac transplant lymphoproliferation. Blood 86: 3333

    PubMed  Google Scholar 

  106. Thomas JA, Hotchin NA, Allday MJ, Amlot P, Rose M, Yacoub M, Crawford DH (1990) Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation 49: 944

    PubMed  Google Scholar 

  107. Trpkov K, Marcussen N, Rayner D, Lam G, Solez K (1997) Kidney allograft with a lymphocytic infiltrate: acute rejection, posttransplantation lymphoproliferative disorder, neither, or both entities? Am J Kidney Dis 30:449

    PubMed  Google Scholar 

  108. Weissmann DJ, Ferry JA, Harris NL, Louis DN, Delmonico F, Spiro I (1995) Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin. Am J Clin Pathol 103: 748

    PubMed  Google Scholar 

  109. Whiteside TL, Herberman RB (1994) Adoptive immunotherapy of cancer. Clin Immunother 2:13

    Google Scholar 

  110. Wood A, Angus B, Kestevan P, Dark J, Notarianni G, Miller S, Howard M, Proctor S, Middleton P (1997) Alpha interferon gene deletions in post-transplant lymphoma. Br J Haematol 98: 1002

    PubMed  Google Scholar 

  111. Young L, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson A, Kieff E, Cohen JI (1989) Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321:1080

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Pittsburgh Medical center, Room E1549 Bioscience Tower, 15213, Pittsburgh, PA, USA

    Michael A. Nalesnik

Authors
  1. Michael A. Nalesnik
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nalesnik, M.A. Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD). Springer Semin Immunopathol 20, 325–342 (1998). https://doi.org/10.1007/BF00838047

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00838047

Keywords

Search

Navigation